Completion pancreatectomy (CP), is an effective, and potentially curative option for selected patients with local recurrence of pancreatic neoplasms in the remnant pancreas after initial pancreatoduodenectomy (PD). Traditionally CP has been performed via the open approach. Reports of minimally-invasive CP particularly after previous open PD are rare. We present a case of a 72-year old male who previously underwent open PD 5 years ago for intraductal papillary mucinous neoplasm (IPMN) with high grade dysplasia in the uncinate process. He had multifocal IPMN and low-risk lesions in the body and tail were managed conservatively. On routine surveillance, the cyst in the body was noted to be increasing in size with the development of a non-enhancing solid component confirmed on magnetic resonance imaging and subsequent endoscopic ultrasonography. The patient underwent successful robotic assisted laparoscopic completion pancreatectomy. 
INTRODUCTION
Today, completion pancreatectomy (CP) remains a relatively rare procedure which is technically demanding to perform and is associated with a high morbidity and mortality rate. 1 The most common indications for CP include its use as a salvage procedure for patients who have experienced severe complications from postoperative pancreatic fistula after pancreaticoduodenectomy (PD) or for patients who have developed a local recurrence of pancreatic neoplasm after previous PD. [2] [3] [4] Over the past decade, the application of minimally invasive surgery for pancreatectomies has rapidly expanded with improvements in surgical technique and surgical equipment. [5] [6] [7] Presently, laparoscopic or robotic distal pancreatectomies has become the surgical approach of choice in many expert pancreatic centers world-wide due to its advantages over the conventional open approach such as shorter length of stay, earlier convalescence and decreased wound infection rate. [6] [7] [8] Minimally-invasive DP has become widely accepted as opposed to PD as it is less technically demanding and does not require the surgeon to perform multiple complex surgical anastomoses. 8 Not surprisingly, the adoption of minimally-invasive PD (MIPD) remains more limited today and is only routinely performed by a few surgeons practicing at specialized highvolume centers. 9, 10 Presently, there are very limited reports in the literature on the use of laparoscopy or robotic surgery for CP particularly after open PD. 2 This is likely due to rarity of CP performed as an elective procedure as isolated local recurrence of pancreatic neoplasms are a rare occurrence.
Furthermore, due to the technical complexity of the procedure, most of these operations have been performed via Nonetheless, the minimally-invasive approach for CP has been rarely reported and to the best of our knowledge only 2 studies 2,15 reporting on 3 cases have been published to date (Table 1) . This is likely due to the combination In conclusion, we demonstrated the feasibility and safety of robotic assisted laparoscopic CP after open PD. This study demonstrates that the minimally-invasive approach can be considered in selected patients allowing these patients to benefit from the MIS approach. Further studies with a larger patient cohort are needed to confirm these findings.
